BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20425756)

  • 1. Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen.
    Truan JS; Chen JM; Thompson LU
    Mol Nutr Food Res; 2010 Oct; 54(10):1414-21. PubMed ID: 20425756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.
    Saggar JK; Chen J; Corey P; Thompson LU
    Mol Nutr Food Res; 2010 Mar; 54(3):415-25. PubMed ID: 19904759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice.
    Truan JS; Chen JM; Thompson LU
    Nutr Cancer; 2012; 64(1):65-71. PubMed ID: 22136581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways.
    Saggar JK; Chen J; Corey P; Thompson LU
    Nutr Cancer; 2010; 62(4):533-42. PubMed ID: 20432175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flaxseed oil enhances the effectiveness of trastuzumab in reducing the growth of HER2-overexpressing human breast tumors (BT-474).
    Mason JK; Fu M; Chen J; Thompson LU
    J Nutr Biochem; 2015 Jan; 26(1):16-23. PubMed ID: 25441844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor.
    Chen J; Stavro PM; Thompson LU
    Nutr Cancer; 2002; 43(2):187-92. PubMed ID: 12588699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary flaxseed-trastuzumab interactive effects on the growth of HER2-overexpressing human breast tumors (BT-474).
    Mason JK; Fu MH; Chen J; Yu Z; Thompson LU
    Nutr Cancer; 2013; 65(3):451-9. PubMed ID: 23530645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
    Chen J; Hui E; Ip T; Thompson LU
    Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice.
    Chen J; Saggar JK; Corey P; Thompson LU
    Br J Nutr; 2011 Feb; 105(3):339-47. PubMed ID: 21138602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of sesame seed and tamoxifen on tumor growth and bone health in athymic mice.
    Sacco SM; Power KA; Chen J; Ward WE; Thompson LU
    Exp Biol Med (Maywood); 2007 Jun; 232(6):754-61. PubMed ID: 17526767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flaxseed oil-trastuzumab interaction in breast cancer.
    Mason JK; Chen J; Thompson LU
    Food Chem Toxicol; 2010; 48(8-9):2223-6. PubMed ID: 20580760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.
    Lee EJ; Oh SY; Sung MK
    Food Chem Toxicol; 2012 Nov; 50(11):4136-43. PubMed ID: 22926442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen.
    Chen J; Saggar JK; Ward WE; Thompson LU
    J Toxicol Environ Health A; 2011; 74(12):757-68. PubMed ID: 21541878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lignan-rich sesame seed negates the tumor-inhibitory effect of tamoxifen but maintains bone health in a postmenopausal athymic mouse model with estrogen-responsive breast tumors.
    Sacco SM; Chen J; Power KA; Ward WE; Thompson LU
    Menopause; 2008; 15(1):171-9. PubMed ID: 17545920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancer.
    Massarweh S; Osborne CK; Jiang S; Wakeling AE; Rimawi M; Mohsin SK; Hilsenbeck S; Schiff R
    Cancer Res; 2006 Aug; 66(16):8266-73. PubMed ID: 16912207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.